Scott M. Coiante - Jan 2, 2025 Form 3 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, Chief Financial Officer
Signature
/s/ Scott M. Coiante
Stock symbol
LXRX
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
3
Date filed
1/2/2025, 04:06 PM
Previous filing
Aug 26, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LXRX Stock Option (Right to Buy) Jan 2, 2025 Common Stock 230K $0.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.